Entity family
Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.
This disease is selected. Its supporting articles are shown below.
…e remain key challenges that limit the therapeutic potential in solid tumors. T cells are hardwired to pursue a natural path of differentiat…
…y targeting epidermal growth factor receptor (EGFR) in advanced solid tumors with human leukocyte antigen (HLA) loss of heterozygosity (LOH)…
…bserved in solid tumors including melanoma, thyroid cancer, and oral head and neck squamous cell carcinoma with responses lasting over 600 days in some patients. TCR sequ…
…particularly in hematologic malignancies, but their efficacy in solid tumors remains limited. Key barriers include tumor antigen heterogenei…
…e treatment of hematological cancers but less effective against solid tumors, a phenomenon that results from the immunosuppressive nature of…
…ating hematological malignancies; however, their application to solid tumors remains challenging due to the hostile tumor microenvironment (…
…DXs of different histopathology, including, but not limited to, osteosarcoma, Ewing’s sarcoma, liposarcoma, myxofibrosarcoma, synovia sarcom…
…ce the development of next-generation cell-based treatments for solid tumors.…
…t for cancer immunotherapy that is highly prevalent in multiple solid tumors. It is characterised by minimal presence in normal tissues, hom…
…therapy has been successful against solid tumors. 1 Efficacy in solid tumors is hampered by various factors such as antigen variation, lack …
…Background Solid tumors such as breast, lung, pancreatic, colorectal, and ovarian cance…